Search results for: “Matthew Riddle”
-
Experts will discuss strategies to minimize COVID-19 risks for diabetes patients
The 2021 Diabetes Care Symposium, featuring speakers Matthew C. Riddle, MD, and Paresh Dandona, MD, PhD, will examine how to mitigate the threefold risk for severe COVID-19 infection among diabetes patients.
-
REWIND trial: Dulaglutide reduces cardiovascular disease in type 2 diabetes patients
Dulaglutide, an injectable GLP-1 receptor agonist, can be considered for both primary and secondary cardiovascular prevention in middle-aged and older patients with type 2 diabetes and cardiovascular risk factors, according to results from the REWIND trial reported by Hertzel C. Gerstein, MD, MSc, FRCPC, and Matthew C. Riddle, MD.
-
Experts offer their long-term perspectives during annual Diabetes Care Symposium
During the ninth annual Diabetes Care Symposium, a panel of world-renowned clinicians and researchers emphasized the need to consider all aspects of diabetes over long periods of time rather than relying on short-term clinical studies, single clinical assessments of individual patients, and short-term therapeutic goals. Diabetes Care Editor in Chief Matthew C. Riddle, MD, moderated…
-
Although incomplete, data indicate strong link between diabetes and COVID-19
The ADA Diabetes Care Symposium, with speakers Edward W. Gregg, PhD, and Linda DiMeglio, MD, MPH, focused on minimizing risks for people with diabetes during the pandemic. This population accounts for 30% to 40% of hospitalized COVID-19 patients.
-
New data underscores importance of GIP signaling in the brain to regulating food intake, energy balance
“The central nervous system is an important target organ for GLP-1 and GIP pharmacotherapy to affect energy balance,” said Alice Adriaenssens, PhD, in the ADA Diabetes Symposium.
-
Presenter Profile: Building Diabetes Care Capacity in Rural Underserved Communities—A Comparison of Cardiorenal Risk Factor Outcomes in Patients Treated by ECHO-Trained Providers vs. an Academic Medical Center
Matthew Bouchonville, MD, CDCES, previews a presentation at the 83rd Scientific Sessions. Attendees in San Diego can watch the session in-person Sunday, June 25, at 11:30 a.m. PT, and select recordings will be available on the meeting’s virtual platform after the live presentations.
-
Sex affects metabolism and glucose homeostasis through multiple mechanisms
Of the three factors that affect sex-based differences in metabolism, panelist Yong Xu, MD, PhD, said the most obvious is gonadal hormones, testosterone and estradiol, and their receptor signaling. The most fundamental factor is sex-linked chromosomes, and the most ignored is autosomal genes, he explained.
-
The Bexagliflozin Efficacy and Safety Trial (BEST): A Randomized, Double-Blind, Placebo-Controlled, Phase IIII, Clinical Trial
John JV McMurray, OBE, BSc (Hons), MB, ChB (Hons), MD, Professor of Medical Cardiology, University of Glasgow, previews his presentation “The Bexagliflozin Efficacy and Safety Trial (BEST): A Randomized, Double-Blind, Placebo-Controlled, Phase IIII, Clinical Trial,” which begins at 6 p.m. CT Friday, June 12.
-
Meet the Speaker: Isha Jain, PhD
Session Chair Matthew Hirschey, PhD, interviews Isha Jain, PhD, the first of three speakers planned for Effect of Metabolic Stress on Insulin Action on Sunday morning, June 14. Dr. Jain’s presentation, “Role of Hypoxia in Mediating Metabolic Improvements,” begins at 8:00 a.m. CT.
-
Meet the Speaker: Juleen R. Zierath, PhD
Session Chair Matthew Hirschey, PhD, interviews Juleen R. Zierath, PhD, one of the speakers planned for the symposium Effect of Metabolic Stress on Insulin Action on Sunday morning, June 14. Dr. Zierath’s presentation, “Molecular Benefits of Exercise in Countering Metabolic Stress,” begins at 8:40 a.m. CT.